In the pharmaceutical industry, the margin for error is zero. When you’re managing high-stakes production lines and sensitive intellectual property, your visitor management process needs to be as rigorous as your manufacturing standards.
In a recent guest article for Pharmaceutical Manufacturer, our Executive Vice President of Experiences and Design, Chris Burton, outlines how modern visitor management can transform a potential vulnerability into a strategic point of resilience. For pharma facilities, the challenge isn’t just knowing who is in the building; it’s ensuring every guest — from contractors to auditors — has met strict compliance and safety requirements before they ever set foot on the factory floor.
By moving away from manual, paper-based logs, organisations can create a “compliance-first” entry point. This digital-first approach allows for automated health and safety inductions, instant NDA signatures, and real-time visibility across multiple sites. It ensures that you aren’t just reacting to risks, but proactively building a secure environment that stands up to the most demanding regulatory audits.
-
Key Takeaways
-
-
- Standardise Compliance:
- Automate the collection of NDAs and safety certifications to ensure 100% adherence to GxP and site-specific regulations before access is granted.
- Enhance Intellectual Property Protection:
- Use digital workflows to verify visitor identities and restrict access to sensitive R&D or production areas, creating a clear digital audit trail.
- Eliminate Audit Stress:
- Maintain a single, time-stamped digital source of truth that makes preparing for regulatory inspections fast, accurate, and paperless.
- Ensure all visitors and contractors have viewed mandatory safety briefings and can be accounted for instantly on any device during an emergency evacuation.
-
-
-
Originally published in Pharmaceutical Manufacturer.